Claire Biot

Claire Biot was appointed Vice President, Life Sciences & Healthcare Industry in 2019. Her multifaceted experience in healthcare-related research, business and government administration supports Dassault Systèmes’ aim to drive digital transformation in Life Sciences & Healthcare Industry. As Life Sciences companies shift their focus to precision medicine, she is responsible for helping companies adopt a new unified approach to sustainable innovation by using a scientific and business platform to improve the patient or physician experience. Claire also drives Dassault Systèmes long-term growth in healthcare, leveraging virtual twin experiences to achieve medical practice excellence and value-based care. 

Claire BIOT holds an MSc in Engineering from Ecole polytechnique (Paris, France) and an MSc in Biological Sciences from the Watson School of Biological Sciences (Cold Spring Harbor Laboratory, NY, USA). She studied cancer immunotherapy at Institut Pasteur (Paris, France), where she graduated with a PhD in immunology in 2012, and she holds a Honorary Doctorate from Long Island University, NY, USA (2023). 

Claire began her career at the French Ministry of Health as Head of Division, Health Products Pricing and Reimbursement (2012-2015). She then joined Greater Paris University Hospitals (AP-HP, Paris, France, 2015-2019), where she was appointed Managing Director of the Health Products and Technologies Central Agency, allowing her to build strong experience in health products development, manufacturing and procurement as well as patient care. Claire joined Dassault Systèmes in March 2019. Claire BIOT is an independent Board Member at Mauna Kea Technologies. She is Knight (Chevalier) in the National Order of Merit and has been named Young Leader 2022 by the French-American Foundation. She has been named Qualified Person by the French Prime Minister in a Mission on health products spending (Jan-Aug 2023).